Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
Peter Bou Dib, Key Account Manager at Sino Biological Europe, shared a post on LinkedIn:
“Every day, thousands rely on a tiny but mighty protein to keep their blood flowing safely, Factor IX.
This protein, discovered from a young patient named Stephen Christmas, quietly plays a life-saving role in the complex dance of blood clotting.
Without Factor IX, people with Hemophilia B face constant risks of severe bleeding, impacting their daily lives and dreams.
Thanks to decades of research and innovation, treatments like recombinant Factor IX and emerging gene therapies offer hope and freedom.
Science continues to transform challenges into possibilities, turning a rare protein deficiency into a story of resilience and renewed life.
Here’s to the breakthroughs that rewrite what’s possible.
Want to learn more about proteome in under a minute every day?
Follow Five days, one play, one antigen each day!”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments